David Grainger
2023
In 2023, David Grainger earned a total compensation of $1.4M as Former Chief Innovation Officer at Centessa Pharmaceuticals plc, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $214,562 |
|---|---|
| Option Awards | $310,381 |
| Salary | $520,612 |
| Stock Awards | $297,220 |
| Other | $20,824 |
| Total | $1,363,599 |
Grainger received $520.6K in salary, accounting for 38% of the total pay in 2023.
Grainger also received $214.6K in bonus, $310.4K in option awards, $297.2K in stock awards and $20.8K in other compensation.
Rankings
In 2023, David Grainger's compensation ranked 877th out of 2,983 executives tracked by ExecPay. In other words, Grainger earned more than 70.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 877 out of 2,983 | 71st |
Division Manufacturing | 513 out of 1,637 | 69th |
Major group Chemicals And Allied Products | 349 out of 906 | 62nd |
Industry group Drugs | 339 out of 869 | 61st |
Industry Pharmaceutical Preparations | 230 out of 627 | 63rd |
Source: SEC filing on May 9, 2024.
Grainger's colleagues
We found three more compensation records of executives who worked with David Grainger at Centessa Pharmaceuticals plc in 2023.